Garden City, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that its flagship diagnostic ...
Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback